Pathways for complementary medicine products
This tool will assist potential sponsors of complementary medicines to determine the most suitable pathway to enter their product in the Australian Register of Therapeutic Goods (ARTG).
On 19 March 2018, a new assessed listed medicines pathway was introduced. The assessed listed medicines pathway sits between the current listed (lower risk) and registered (higher risk) pathways. This tool assists potential and existing complementary medicine sponsors to determine which of the three pathways is most suitable for their product.
Make sure you understand the overview of the regulation of complementary medicines in Australia before you start.